Spyre Therapeutics, Inc. (SYRE)
SYRE price $92.94 -0.01 -0.02%
- Ticker
- SYRE
- Price
- $92.94
- Change
- -0.01 -0.02%
- Market cap
- $8.58B
- P/E
- -47.67
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 54
Spyre Therapeutics, Inc. is a biotechnology firm operating at the preclinical stage, dedicated to creating innovative treatments for individuals afflicted with inflammatory bowel disease (IBD). Among its pipeline candidates is SPY001, a human monoclonal immunoglobulin G1 antibody specifically engineered to target and bind with the a4ß7 integrin. This particular therapy is under development for addressing both…